The Ohio State University (OSU) SCREEN Community Program

NCT06666192 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2067

Last updated 2025-12-24

No results posted yet for this study

Summary

This clinical trial develops and tests how well a multi-level intervention (MLI), The Ohio State University (OSU) SCREEN Community Program, works to increase screening and follow-up for breast, cervical and colorectal (CRC) cancer among low-income and un/underinsured female residents in three counties in Central Ohio. In Ohio, incidence and mortality rates for breast, cervical and CRC are higher than or similar to the national average; in addition, underserved populations - minority, rural and low-income women - have higher rates of these cancers. Screening can detect precancerous colorectal and cervical lesions and other early-stage cancers when treatment is less intensive and more successful and is known to reduce mortality rates for breast, cervical, and CRC, however many of these women lack access to health care and screenings. This MLI includes clinic-based components, such as patient education, as well as community-based strategies, such as media programs and training health workers, that can increase rates of guideline-recommended breast, cervical and CRC screening and follow-ups in underserved populations. The OSU SCREEN Community Program may be an effective way to improve breast, cervical and CRC screenings among underserved women in Ohio.

Conditions

  • Breast Carcinoma
  • Cervical Carcinoma
  • Colorectal Carcinoma

Interventions

OTHER

Cancer Screening

Undergo cancer screening

OTHER

Discussion

Participate in discussions

OTHER

Educational Activity

Receive coaching calls

OTHER

Educational Intervention

Receive educational materials

BEHAVIORAL

Focus Group

Participate in focus group

OTHER

Health Care Delivery

Integrate new activities into usual clinic processes

OTHER

Health Promotion

Promote screening and wellness visits

OTHER

Health Promotion and Education

Participate in educational sessions

OTHER

Health Promotion and Education

Participate in early wave MLI

OTHER

Health Promotion and Education

Participate in late wave MLI

BEHAVIORAL

Health Risk Assessment

Incorporate risk assessments

PROCEDURE

Implementation

Implement MLI

OTHER

Informational Intervention

Review MLI materials

OTHER

Internet-Based Intervention

Receive educational online materials

OTHER

Interview

Participate in interview

BEHAVIORAL

Outreach

Receive outreach activities

BEHAVIORAL

Patient Navigation

Receive access to CHW

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

  • American Cancer Society, Inc.

    collaborator OTHER
  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Electra D Paskett, PhD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06666192 on ClinicalTrials.gov